Comparison of the effect Emla Cream? local lavender essential oil and Cold Compress on the pain intensity of the injection site and Comfort of heart Patients Receiving Enoxaparin

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20100829004655N9

Enrollment

100

Registered

2018-03-25

Start date

2018-04-04

Completion date

Unknown

Last updated

2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injection pain. Other acute postprocedural pain

Interventions

Intervention 1: First intervention group :In this method 1gr Emla cream is placed on the injection site with holder dressing 60 minute before the injection and dressing is removed after the one hour,

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.age between 18-85 years old full consciousness ability to communicate not a severe pain in other areas no history of prescribed Enoxaparin no scarring and lesions at the injection site no history of allergy to lidocaine & Prilocain no history of allergy to Lavender

Exclusion criteria

Exclusion criteria: loss of consciousness prescription of narcotic and non-narcotic analgesics 2 hours before injection injection of other drug in the abdomen during the study

Design outcomes

Primary

Measure	Time frame
Injection pain. Timepoint: Immediate,5 &10 minute after injection. Method of measurement: Using the VAS scale & record severe pain intensity.;The amount Patient comfort. Timepoint: Immediate,5 &10 minute after injection. Method of measurement: visual scale of comfor& record severe comfort intensity Using the.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactbadry torki

Kashan University of Medical Sciences

taghadosi_m@kaums.ac.ir+98 31 5554 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026